Verification evidence is still being completed.
PDF / print export
3PBIOVIAN
Turku, Finland
- Verified lead
- Damaso Molero
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Biologics CDMO, Viral Vectors, Plasmid DNA, and Aseptic Fill and Finish
- Review cycle
- May 2026
- Full address
- Tykistokatu 6A, Biocity, FI-20520 Turku, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official 3PBIOVIAN executive-team announcement quoting Damaso Molero as CEO.
- Editorial note
- The Finland record is published under the current 3PBIOVIAN brand, which absorbed BIOVIAN in 2024 and now presents the Turku site as part of a dual-site pan-European CDMO network.
Biologics CDMO, Viral Vectors, Plasmid DNA, and Aseptic Fill and Finish
EMA-certified GMP production, FDA-inspected GMP manufacturing
The Finland record is published under the current 3PBIOVIAN brand, which absorbed BIOVIAN in 2024 and now presents the Turku site as part of a dual-site pan-European CDMO network.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
3PBIOVIAN runs viral vector manufacturing, microbial protein manufacturing, and plasmid dna in Turku, Finland.
- Lead
- Damaso Molero (verified ↗)
- Address
- Tykistokatu 6A, Biocity, FI-20520 Turku, Finland (source ↗)
- Compliance
- EMA-certified GMP production · FDA-inspected GMP manufacturing
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Investigational to commercial GMP manufacturing
- Capabilities
- Viral Vector Manufacturing · Microbial Protein Manufacturing · Plasmid DNA
- Founded
- 2024
- Headcount
- 501-1000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Damaso Molero
Chief Executive Officer
Full addressTykistokatu 6A, Biocity, FI-20520 Turku, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official 3PBIOVIAN Turku location page listing the Biocity address and local service scope.
Open sourceInvestigational to commercial GMP manufacturing
Turku, Finland. Biologics CDMO, Viral Vectors, Plasmid DNA, and Aseptic Fill and Finish. Review completed on 21 Mar 2026.
Fimea, EMA, FDA, and biopharmaceutical GMP oversight
EMA-certified GMP production, FDA-inspected GMP manufacturing
Biologics CDMO, Viral Vectors, Plasmid DNA, and Aseptic Fill and Finish
The Finland record is published under the current 3PBIOVIAN brand, which absorbed BIOVIAN in 2024 and now presents the Turku site as part of a dual-site pan-European CDMO network.
Editorial note
The Finland record is published under the current 3PBIOVIAN brand, which absorbed BIOVIAN in 2024 and now presents the Turku site as part of a dual-site pan-European CDMO network.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Viral Vector Manufacturing
Microbial Protein Manufacturing
Plasmid DNA
Aseptic Fill and Finish
QC Services
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Viral-vector manufacturing suites
Microbial production systems
Aseptic fill-finish and QC laboratories
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- VERIFIED ACTIVE 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is 3PBIOVIAN located?
- 3PBIOVIAN operates from Tykistokatu 6A, Biocity, FI-20520 Turku, Finland, Turku, Finland.
- Who runs 3PBIOVIAN?
- 3PBIOVIAN is led by Damaso Molero, Chief Executive Officer. Verified 21 Mar 2026.
- What certifications does 3PBIOVIAN hold?
- 3PBIOVIAN is documented under EMA-certified GMP production, FDA-inspected GMP manufacturing.
- What does 3PBIOVIAN do?
- 3PBIOVIAN runs viral vector manufacturing, microbial protein manufacturing, and plasmid dna in Turku, Finland. Core capabilities: Viral Vector Manufacturing, Microbial Protein Manufacturing, Plasmid DNA, Aseptic Fill and Finish.
Editorial context
Related technical briefs
Briefs that name Turku as a covered market or city.